BioXcel Therapeutics, Inc. Common Stock
$1.135
USD
Last updated on --.
24h volume272.29K
24h highest1.1600 USD
24h lowest1.0710 USD
24h Price movement+2.25%
BTAI recent prices
24 Hours
+2.25%+$0.025
30 days
-5.04%-$0.06
60 days
+10.78%+$0.11
90 days
-26.51%-$0.395
Key data
Previous close1.1100 USD
Market cap34.12M USD
Volume272.29K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.4400 USD
Net income (FY)-75.33M USD
Revenue (FY)680.00K USD
Last report dateMay 15, 2026
About BioXcel Therapeutics, Inc. Common Stock
HeadquartersNEW HAVEN
Employees (FY)29.00
Revenue per employee (FY)23.45K USD
Net income per employee (FY)-2.60M USD
Listed onNasdaq
BTAI conversion tables
 |  |
|---|---|
| 0.5 BTAI | 0.5675 USD |
| 1 BTAI | 1.135 USD |
| 5 BTAI | 5.675 USD |
| 10 BTAI | 11.35 USD |
| |
|---|---|
| 0.5 USD | 0.44053 BTAI |
| 1 USD | 0.88106 BTAI |
| 5 USD | 4.405 BTAI |
| 10 USD | 8.810 BTAI |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BTAI is trading at $1.135, +2.25% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BTAI stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BTAI is currently trading at $1.135, +2.25% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BTAI price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BTAI's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BTAI; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BTAI's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
BioXcel Therapeutics, Inc. Common Stock's market cap is currently 34.12M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume272.29K
24h highest1.1600 USD
24h lowest1.0710 USD
24h Price movement+2.25%
Start trade with BTAI Perpetual
Sign up to trade